Advertisement
Screener

Health Catalyst, Inc. (HCAT) Spending and interest coverage

Health Catalyst, Inc. (HCAT) Spending and interest coverage

  • R&D / revenue · 12 months: Value 14.71%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 6.03%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months14.71%Research and development expense / revenue. Period ending 2026-06-30.

$43.00M ÷ $292.25M × 100 ≈ 14.71%

Stock-based compensation / revenue · 12 months6.03%Share-based compensation / revenue. Period ending 2026-06-30.

$17.63M ÷ $292.25M × 100 ≈ 6.03%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending43.00M USDResearch and Development Expense
Revenue292.25M USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation17.63M USDShare-based Payment Arrangement, Noncash Expense
Operating income-246.55M USDOperating Income (Loss)
Interest expense · reported / estimated(m) · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30$43.00M$292.25M$17.63M$-246.55M(m)14.71%6.03%(m)(m)
2026-03-31$44.36M$302.48M$23.24M$-247.16M(m)14.67%7.68%(m)(m)
2025-12-31$49.77M$311.14M$27.01M$-160.85M(m)16.00%8.68%(m)(m)
2025-09-30$54.86M$316.06M$33.72M$-92.27M(m)17.36%10.67%(m)(m)
2025-06-30$56.77M$316.09M$36.19M$-88.45M(m)17.96%11.45%(m)(m)
2025-03-31$58.27M$311.27M$36.83M$-67.17M(m)18.72%11.83%(m)(m)
2024-12-31$57.95M$306.58M$40.13M$-69.81M(m)18.90%13.09%(m)(m)
2024-09-30$63.24M$302.06M$42.33M$-85.09M(m)20.93%14.01%(m)(m)
2024-06-30$66.71M$299.48M$47.05M$-95.98M(m)22.28%15.71%(m)(m)
2024-03-31$70.42M$296.79M$52.71M$-114.80M(m)23.73%17.76%(m)(m)
2023-12-31$72.63M$295.94M$55.76M$-126.90M(m)24.54%18.84%(m)(m)
2023-09-30$71.95M$290.02M$61.49M$-130.86M(m)24.81%21.20%(m)(m)
2023-06-30$75.06M$284.60M$64.56M$-152.00M(m)26.37%22.69%(m)(m)
2023-03-31$75.61M$282.02M$67.87M$-150.57M(m)26.81%24.07%(m)(m)
2022-12-31$75.68M$276.24M$72.10M$-140.00M(m)27.40%26.10%(m)(m)
2022-09-30$73.55M$271.79M$69.78M$-148.03M(m)27.06%25.67%(m)(m)
2022-06-30$69.16M$265.17M$69.96M$-144.55M(m)26.08%26.38%(m)(m)
2022-03-31$65.54M$254.17M$69.75M$-143.68M(m)25.78%27.44%(m)(m)
2021-12-31$62.73M$241.93M$65.14M$-143.65M(m)25.93%26.93%(m)(m)
2021-09-30$60.23M$230.49M$59.40M$-137.81M(m)26.13%25.77%(m)(m)
2021-06-30$57.24M$215.94M$51.41M$-119.02M(m)26.51%23.81%(m)(m)
2021-03-31$54.77M$199.57M$42.73M$-102.34M(m)27.45%21.41%(m)(m)
2020-12-31$53.52M$188.84M$37.96M$-96.13M(m)28.34%20.10%(m)(m)
2020-09-30$51.58M$179.07M$32.10M$-70.88M(m)28.81%17.93%(m)(m)
2020-06-30$51.67M$171.30M$32.58M$-68.15M(m)30.16%19.02%(m)(m)
2020-03-31$49.32M$164.84M$24.93M$-61.88M(m)29.92%15.12%(m)(m)
2019-12-31$46.25M$154.94M$17.84M$-54.87M(m)29.85%11.52%(m)(m)
2019-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-12-31$38.59M$112.57M$4.20M$-60.09M(m)34.28%3.73%(m)(m)
2018-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-12-31$28.47M$73.08M$4.24M$-45.54M(m)38.96%5.80%(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Eva Live Inc (GOAI)United States$0.083B
PodcastOne, Inc. (PODC)United States$0.068B-42.98
Professional Diversity Network, Inc. (IPDN)United States$0.060B
Teads Holding Co. (TEAD)United States$0.045B-0.14
Cardlytics, Inc. (CDLX)United States$0.020B-0.24
INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM)United States$0.016B-4.22
Global Interactive Technologies, Inc. (GITS)$0.008B
TaoWeave, Inc. (TWAV)United States$0.006B
ZW Data Action Technologies Inc. (CNET)$0.005B-5.46
AIRWA INC. (YYAI)United States$0.004B-101.45